Asaf Shiloni, a veteran biotech founder and manager is the CEO of Kadimastem a clinical stage biotech company, that is creating cell therapy that enables the production of off-the-shelf cell-based products for the treatment of unmet medical needs such as ALS and a cure for Diabetes.
Avraham sat down with Asaf in the offices of Kadimastem to discuss how Kadimastem is creating and testing their innovative therapies, why Israeli startups are so successful, the role of patents in Kadimastem’s business, tips for startup founders and much more.
Do you have a great innovation? We’d love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup.
Also available at https://soundcloud.com/jmbdavis/asaf-shiloni-of-kadimastem. Listen to all of the episodes at https://jmbdavis.com/podcast.